Saama Technologies

23 articles about Saama Technologies

• Saama Hires Life Sciences Expert, Dr. Clinton White, as Chief Delivery Officer

  11/15/2022

  Life sciences solutions company Saama has hired Clinton White, Ph.D., MBA, to serve as Chief Delivery Officer.

• Biopharma Industry Leaders Ian Read and Clive Meanwell Join Saama Board of Directors

  11/19/2021

  Highly respected industry leaders including Ian Read, former CEO and Executive Chairman of Pfizer, and Clive Meanwell, Founder and former CEO of The Medicines Company, join Saama’s Board of Directors.

• 

  Pfizer COVID Vaccine Contributor Saama Lands $430 Million Investment

  10/21/2021

  Saama Technologies secured a $430 million investment from the Carlyle Group and venture funds from some of the pharmaceutical industry’s biggest companies.

• Carlyle and Leading Healthcare-Focused Venture Funds Announce Strategic Growth Investment of up to $430 Million in Saama

  10/20/2021

  The partnership will allow Saama to accelerate its strategic initiatives, including expanding its go-to-market capabilities and further investing in AI research and development.

• Saama Announces Support for AWS Health Initiative

  7/15/2021

  Saama Technologies, Inc. (“Saama”) announced today the company’s support for the AWS for Health initiative from Amazon Web Services (AWS).

• Dr. Ajit Shetty Awarded Honorary Doctorate from Ghent University

  3/19/2021

  Saama Technologies, Inc. (“Saama”) announced today that Saama Board Director Ajit Shetty, Ph.D., received an honorary doctorate degree from Ghent University’s Faculty of Pharmaceutical Sciences for his services to science and research.

• Saama Appoints Ian Holmes, Ph.D., to Swiss Board of Directors

  1/14/2021

  Saama Technologies, Inc. (“Saama”), the #1 AI clinical analytics platform company, announced today that Ian Holmes, Ph.D., has joined its Swiss Board of Directors, effective January 1, 2021.

• Saama Designated One of 2020’s Most Innovative Companies In Healthcare for Accelerating Clinical Trials with Advanced Analytics

  11/30/2020

  Saama Technologies, Inc. (“Saama”), the #1 AI clinical analytics platform company, announced today that it has been named to the “2020 Inaugural List of Most Innovative Companies in Healthcare.”

• Saama Appoints William H. Carson, M.D., to Board of Directors

  11/10/2020

  Saama Technologies, Inc. (“Saama”), the #1 AI clinical analytics platform company, announced today that it has appointed William H. Carson, M.D., Chairman of the Board at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), to the Saama Board of Directors effective October 16, 2020.

• Saama Launches Active Safety Analytics for Pharma (ASAP), Co-built With Gilead to Transform Safety Surveillance

  10/26/2020

  Saama Technologies, Inc., the #1 AI clinical analytics platform company, announced the launch of the new Active Safety Analytics for Pharma product.

• Saama and iNDX.Ai Launch New COVID-19 Command Center Analytics Platform To Expedite Clinical Research Efforts by Individual Sponsors

  5/5/2020

  Saama Technologies, Inc., the #1 AI clinical analytics platform company, and iNDX.Ai, a leading Multi-omics Data Analytics and translational research platform company, announced the launch of the new COVID-19 Command Center.

• Saama Makes State-of-the-Art Clinical Analytics Platform Available to Integrate Data from all Organizations Investigating COVID-19 Treatments

  3/30/2020

  Saama Technologies, Inc. (“Saama”), the #1 AI clinical analytics platform company, announced today that it will contribute its AI-powered Life Science Analytics Cloud (LSAC) technology platform to establish the EndPandemic National Data Consortium.

• Saama and Pfizer to Transform Work of Clinical Data Managers and Monitors With AI

  2/18/2020

  Feb. 18, 2020 14:44 UTC CAMPBELL, Calif.--( BUSINESS WIRE )-- Saama Technologies, Inc. , the number one AI clinical analytics platform company, announced today that it signed an agreement with Pfizer Inc. to develop and deploy an AI-powered analytics solution to reduce the challenges commonly experienced by clinical study data managers and monitors. Under this agreement, Saama’s award-winning Life Science Analytics Cloud (LSAC) platform will aggregate, transform, analyze, mod

• Saama’s Growth Strategy Continues with Addition of Jonathan Burr and Gregory Simpson to Leadership Team

  2/18/2020

  Saama Technologies, Inc., the number one AI clinical analytics platform company, announced that it recently expanded its leadership team to include life science technology expert Jonathan Burr as Senior Vice President of Clinical Platform Strategy, and technology marketing leader Gregory T. Simpson as Vice President, Head of Marketing.

• Saama and Comprehend to Form Preeminent Clinical Analytics Platform Company

  8/13/2019

  Transaction Creates Expanded Portfolio of Cloud-Based Capabilities to Advance Clinical Development

• Saama Challenges Analytics Industry to Guarantee Data Platforms to Help Accelerate Drug Development

  5/20/2019

  Company Leads Call-to-Action by Issuing Saama Product Guarantee on Clinical Trials Day

• Saama Closes $40 Million Financing with Perceptive Advisors to Drive Disruption in Clinical Analytics and Drug Development

  3/25/2019

  Saama Technologies, Inc., a leading clinical data analytics platform firm, announced that it has closed a $40 million financing with Perceptive Advisors.

• Saama Unveils New Capabilities for Award-Winning Life Science Analytics Cloud at SCOPE

  2/18/2019

  Saama Technologies, Inc., a leading data analytics company, unveiled three new, machine learning-based capabilities that extend the existing functionality of its award-winning Life Science Analytics Cloud.

• Saama Appoints Six Elite Life Science Industry Experts to Clinical Board of Advisors

  9/10/2018

  Saama Technologies, Inc. today announced the addition of six new members to its Clinical Board of Advisors.

• 

  BioSpace Movers and Shakers for Week of June 4th

  6/11/2018

  Biotech and pharmaceutical companies across the U.S. and globally shook up their senior leadership roles in the first week of June with new hires that included chief executive officers and directors.